Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Johns Hopkins University
With
National Institute on Drug Abuse (NIDA)
We plan to perform liver biopsy by microlaparoscopy on previously untreated HIV/HCV coinfected persons, then give them a dose of peginterferon alfa 2b. HCV and HIV kinetics will be studied. Afterward, HIV will be treated using antiretroviral therapy and the procedure will be repeated.
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult Human
Able to provide written informed consent
HIV antibody positive
HIV viral load positive
HIV treatment naive
Hepatitis C antibody positive
Hepatitis C viral load positive
Hepatitis C treatment naive
Approved to take HIV medications for minimum 9 months
Willing to use contraception, Life expectancy greater than 2 years
You may not be if
Significant opportunistic infections within 12 month
Hepatitis B positive
Evidence of liver cirrhosis
Decompensated liver disease
Chronic alcohol abuse
Allergy to raltegravir, tenofovir, and/or emtricitabine
